Evidence map›Paper›PMID 12675171›Full record

ReviewCanadian journal of public health = Revue canadienne de sante publique

HIV/AIDS mortality in trends in Canada, 1987-1998.

Dena L Schanzer

Abstract readComparative StudyReview
PubMed Full text at PMC
In one paragraph

Review in Canadian journal of public health = Revue canadienne de sante publique. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Regional and temporal changes in HIV-related mortality in British Columbia, 1987-2006.Canadian journal of public health = Revue canadienne de sante publique
    Article
  3. Causes of widening life expectancy inequalities in Québec, Canada, 1989-2004.Canadian journal of public health = Revue canadienne de sante publique
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Dena L SchanzerCentre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada, AL. dena_schanzer@hc-sc.gc.ca

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo monitor Canadian HIV/AIDS mortality following the introduction of antiretroviral therapies in 1996, and to compare this with the US experience.

methodsDeaths were extracted by underlying cause of death, age, sex, marital status and place of residence at time of death. Age-specific leading causes of death, potential years of life lost before age 65, and rates are presented.

resultsHIV deaths peaked in 1995 at 1,764, representing 1% of all deaths, 15% of male deaths aged 25-44, and the second leading cause of death for males age 25-44, trailing suicides. From 1995 to 1997, HIV deaths dropped by 66% for males and 43% for females. Rates for Toronto, Vancouver and Montreal were 6 times higher than in rural areas, and 2.5 times higher than in other Census Metropolitan Areas.

conclusionsAs of 1998, HIV still was a leading cause of premature mortality. The trend in Canadian HIV mortality was similar to that in the US, though US rates remain double the Canadian rates. The drop in HIV deaths may not be sustained in the long term, as antiretroviral therapy is not a cure and the number of people living with HIV is increasing.

Indexed as

AdultAnti-HIV AgentsCanadaFemaleHIV InfectionsHumansMaleNational Health ProgramsUnited StatesAnti-HIV Agents

Identifiers

PMID12675171
PMCPMC6979854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.